American Leprosy Missions, Inc.

The information in this column was provided to MinistryWatch by the ministry itself. It was last updated 5/25/2021. To update the information in this column, please email: info@ministrywatch.com


Summary

American Leprosy Missions is the oldest and largest Christian, non-profit organization in the U.S. dedicated to curing and caring for people affected by leprosy and related diseases around the world. During its more than 100-year history, American Leprosy Missions has provided holistic care to more than four million people including medical treatment and training, medical supply deliveries, health system strengthening, research, community development, and disease mapping and management.


Contact information

Mailing address:
American Leprosy Missions, Inc.
One Alm Way
Greenville, SC 29601-9948

Website: www.leprosy.org

Phone: 800-543-3135

Email: amlep@leprosy.org


Organization details

EIN: 135562163

CEO/President: Mr. Bill Simmons

Chairman: Chris A. Hogue, M.B.A.

Board size: 10

Founder:

Year founded: 1955

Tax deductible: Yes

Fiscal year end: 06/30

Member of ECFA: Yes

Member of ECFA since: 1981


Purpose

More than one billion men, women and children are affected by neglected tropical diseases (NTDs), including leprosy and Buruli ulcer. These diseases affect the poorest and most neglected people and can lead to profound pain and suffering, lifelong disabilities, increased poverty, stigma and isolation.

For more than 100 years, the organization has acted as a channel of Christ's love, helping people suffering from these terrible diseases be healed and restored to lives of dignity and hope.

Today, American Leprosy Missions continues to lead a global fight against NTDs, working to cure and care for those affected, and actually end these devastating diseases in our time.


Mission statement

American Leprosy Missions exists to serve as a channel of Christ's love to persons affected by leprosy and related diseases, helping them to be healed in body and spirit and restored to lives of dignity and hope.


Statement of faith

American Leprosy Missions uses the following to express its Statement of Faith (adopted from the National Association of Evangelicals):

1.We believe the Bible to be the inspired, the only infallible, authoritative Word of God.

2.We believe that there is one God, eternally existent in three persons; Father, Son, and Holy Spirit.

3.We believe in the deity of our Lord Jesus Christ, in His virgin birth, in His sinless life, in His miracles, in His vicarious and atoning death through His shed blood, in His bodily resurrection, in His ascension to the right hand of the Father, and in His personal return in power and glory.

4.We believe that for the salvation of lost and sinful man, regeneration by the Holy Spirit is absolutely essential, and that this salvation is received through faith in Jesus Christ as Savior and Lord and not as a result of good works.

5.We believe in the present ministry of the Holy Spirit by whose indwelling the Christian is enabled to live a godly life and to perform good works.

6.We believe in the resurrection of both the saved and the lost; they that are saved unto the resurrection of life and they that are lost unto the resurrection of damnation.

7.We believe in the spiritual unity of believers in our Lord Jesus Christ, with equality across racial, gender and class differences.

Transparency grade

A

To understand our transparency grade, click here.


Financial efficiency ratings

Sector: Relief and Development

CategoryRatingOverall rankSector rank
Overall efficiency rating913 of 91375 of 75
Fund acquisition rating907 of 91575 of 75
Resource allocation rating888 of 91575 of 75
Asset utilization rating907 of 91375 of 75

Financial ratios

Funding ratiosSector median20202019201820172016
Return on fundraising efforts Return on fundraising efforts =
Fundraising expense /
Total contributions
6%29%19%12%21%19%
Fundraising cost ratio Fundraising cost ratio =
Fundraising expense /
Total revenue
6%29%18%12%20%19%
Contributions reliance Contributions reliance =
Total contributions /
Total revenue
99%99%99%99%97%97%
Fundraising expense ratio Fundraising expense ratio =
Fundraising expense /
Total expenses
6%24%18%16%18%18%
Other revenue reliance Other revenue reliance =
Total other revenue /
Total revenue
1%1%1%1%3%3%
 
Operating ratiosSector median20202019201820172016
Program expense ratio Program expense ratio =
Program services /
Total expenses
86%68%77%81%79%79%
Spending ratio Spending ratio =
Total expenses /
Total revenue
97%121%100%75%111%104%
Program output ratio Program output ratio =
Program services /
Total revenue
83%82%77%60%88%83%
Savings ratio Savings ratio =
Surplus (deficit) /
Total revenue
3%-21%0%25%-11%-4%
Reserve accumulation rate Reserve accumulation rate =
Surplus (deficit) /
Net assets
7%-16%0%31%-13%-5%
General and admin ratio General and admin ratio =
Management and general expense /
Total expenses
7%8%5%3%3%3%
 
Investing ratiosSector median20202019201820172016
Total asset turnover Total asset turnover =
Total expenses /
Total assets
1.720.880.820.901.311.11
Degree of long-term investment Degree of long-term investment =
Total assets /
Total current assets
1.3423.0913.9828.7018.5113.71
Current asset turnover Current asset turnover =
Total expenses /
Total current assets
2.8520.4011.4725.8224.2215.28
 
Liquidity ratiosSector median20202019201820172016
Current ratio Current ratio =
Total current assets /
Total current liabilities
8.491.433.273.471.153.74
Current liabilities ratio Current liabilities ratio =
Total current liabilities /
Total current assets
0.110.700.310.290.870.27
Liquid reserve level Liquid reserve level =
(Total current assets -
Total current liabilities) /
(Total expenses / 12)
3.150.180.730.330.060.58
 
Solvency ratiosSector median20202019201820172016
Liabilities ratio Liabilities ratio =
Total liabilities /
Total assets
13%6%3%2%7%4%
Debt ratio Debt ratio =
Debt /
Total assets
0%2%0%0%0%0%
Reserve coverage ratio Reserve coverage ratio =
Net assets /
Total expenses
48%107%118%109%71%86%

Financials

Balance sheet
 
Assets20202019201820172016
Cash$394,206$1,003,779$369,623$443,145$635,929
Receivables, inventories, prepaids$246,057$185,182$196,366$175,340$245,572
Short-term investments$0$0$0$0$0
Other current assets$0$0$0$0$0
Total current assets$640,263$1,188,961$565,989$618,485$881,501
Long-term investments$8,025,576$9,129,114$9,431,996$4,938,142$5,760,660
Fixed assets$105,675$116,518$122,761$122,025$153,447
Other long-term assets$6,014,739$6,190,315$6,124,573$5,768,632$5,286,119
Total long-term assets$14,145,990$15,435,947$15,679,330$10,828,799$11,200,226
Total assets$14,786,253$16,624,908$16,245,319$11,447,284$12,081,727
 
Liabilities20202019201820172016
Payables and accrued expenses$291,661$196,169$162,950$538,506$234,426
Other current liabilities$157,180$167,851$0$0$1,385
Total current liabilities$448,841$364,020$162,950$538,506$235,811
Debt$277,488$0$0$0$0
Due to (from) affiliates$0$0$0$0$0
Other long-term liabilities$129,205$134,329$142,685$246,281$276,359
Total long-term liabilities$406,693$134,329$142,685$246,281$276,359
Total liabilities$855,534$498,349$305,635$784,787$512,170
 
Net assets20202019201820172016
Without donor restrictions$6,605,815$8,713,791$8,647,824$3,532,940$5,027,876
With donor restrictions$7,324,904$7,412,768$7,291,860$7,129,557$6,541,681
Net assets$13,930,719$16,126,559$15,939,684$10,662,497$11,569,557
 
Revenues and expenses
 
Revenue20202019201820172016
Total contributions$10,661,623$13,465,316$19,277,069$13,123,786$12,529,567
Program service revenue$0$0$0$124,814$0
Membership dues$0$0$0$0$0
Investment income$125,818$118,702$205,927$291,522$399,648
Other revenue$12,738$8,348$1,180$2,331$2,187
Total other revenue$138,556$127,050$207,107$418,667$401,835
Total revenue$10,800,179$13,592,366$19,484,176$13,542,453$12,931,402
 
Expenses20202019201820172016
Program services$8,893,226$10,517,342$11,770,082$11,870,294$10,680,273
Management and general$1,024,287$621,326$499,083$415,799$387,027
Fundraising$3,142,216$2,503,629$2,345,410$2,694,358$2,398,148
Total expenses$13,059,729$13,642,297$14,614,575$14,980,451$13,465,448
 
Change in net assets20202019201820172016
Surplus (deficit)($2,259,550)($49,931)$4,869,601($1,437,998)($534,046)
Other changes in net assets$63,710$236,806$407,586$530,938($780,158)
Total change in net assets($2,195,840)$186,875$5,277,187($907,060)($1,314,204)

Compensation

NameTitleCompensation
David W SimmonsPresident/CEO$203,303
Darren SchauppVP of Programs$140,805
Beverly H ElmoreVP of Finance$127,115
James OehrigChief Programs Officer$126,251
Christina Miller-ColtonVP of Development$119,566
Sarah HesshausVP of Bus. Process & Comm.$107,994
Stefanie WeilandVP Special Initiatives$84,722

Compensation data as of: 6/30/2020


Response from ministry

No response has been provided by this ministry.


The information below was provided to MinistryWatch by the ministry itself. It was last updated 5/25/2021. To update the information below, please email: info@ministrywatch.com


History

In 1906, a group of mission executives, ministers and businessmen met in New York City. Compelled by their faith and spurred by their compassion for some of the most marginalized and impoverished people in the world, these seven men founded what would become American Leprosy Missions.

During the early 1980s, American Leprosy Missions became one of the first organizations to use the new multi-drug therapy, a combination of three antibiotics, to cure leprosy.

During the early 1980s, American Leprosy Missions became one of the first organizations to use the new multi-drug therapy, a combination of three antibiotics, to cure leprosy.

In 2002, the organization began development of the world's first leprosy-specific vaccine.

Today American Leprosy Missions partners with more than 50 organizations around the world on policy development, program coordination, innovative research, advocacy, technical training, community development and more, in order to best serve people affected by leprosy and related diseases.

More information at: www.leprosy.org/leprosy-history


Program accomplishments

Per the 2020 Annual Report:

1,746 health workers in West Africa trained in NTD disability prevention

457 life-changing leprosy surgeries performed at 3 partner hospitals in India and Nepal

$5,080,368 worth of critical medicines and medical supplies sent to Liberia

50,843 people screened for NTDs

$790,495 invested in pioneering research in 21 countries

392 student leaders in India trained in good sanitation and hygiene

1,882 pairs of special footwear distributed

13,162 households in India reached with education on sanitation, hygiene and NTDs

120,000 people in DR Congo reached with public health messages via radio and TV


Needs